New Synthetic Chaperones to Enhance Protein Activity

增强蛋白质活性的新型合成伴侣

• 批准号: EP/V056085/1
• 负责人: Nicholas Turner
• 金额: $ 165.83万
• 依托单位: De Montfort University
• 依托单位国家: 英国
• 项目类别: Fellowship
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=EP%2FV056085%2F1
• 关键词: New; Synthetic; Chaperones; Enhance; Protein

3D structure is fundamental to the biological function, level of activity and very nature of a protein. Key interactions between the protein and its ligand albeit a small molecule or another protein exploit specific structure. Variations in primary, secondary and tertiary structure can therefore result in significant changes in a protein's behaviour. These changes can range from a simple increase or decrease in enzymatic activity caused by alterations to its structure (caused by the presence of another molecular entity); through to the misfold pathogenesis observed in diseases such as Diabetes and Alzheimer's. Nature has developed control mechanisms to regulate structure/function in many biological systems. The big idea here is that nanoscale polymeric materials with exceptional selectivity, affinity and biocompatibility will act as biomimetics of these control mechanisms and influence protein behaviours. The vision is that these materials will act as role-specific artificial chaperones, opening a new field of bio-inspired materials with a single design process but multiple applications.The proposed programme of research is a unified design approach to the development of these artificial biomimetics using the principle of Molecular Imprinting. Molecular modelling techniques will identify target binding sites alongside compatible polymer components. These simple, elegant biomimetics incorporate binding sites bearing steric and chemical functionality complementary to a given target and as such represent a generic, versatile, scalable, cost-effective approach to the creation of synthetic molecular receptors. They currently are used in separation sciences, purification, sensors and catalysis; but this proposal will broaden their application, allowing the technology to reach its true potential. In activities 1 and 2, nanoscale MIPs including aptaMIPs (nucleic acid-hybrids in which the PI is a leading proponent) will be targeted towards specific binding sites (epitope or larger domain) with the aim to modulate the function of its target. The ability to enhance or inhibit enzymatic activity in relevant environments will be explored, all while building an understanding how these materials interact, and how the composition/target site generates the desired activity.In activities 3 and 4, the ability to guide the folding of protein into specific structures will be explored. By providing MIPs that favour binding a specific shape or conformation, we will look at the creation of misfolds to produce biomaterials for further use (tissue engineering). We will also explore the potential of these materials to reduce or reverse misfolding itself, providing proof-of-concept data for potential future therapeutics.Throughout commercial and clinically relevant targets are used to increase impact of the study, but also to show the power of the developed methodologies.The project will use facilities at DMU, and with an experienced project team, this interdisciplinary proposal which covers protein, polymer and analytical chemistry will take a deep-dive approach to MIP synthesis. It will build on existing proof-of-concept ideas, translating novel synthetic processes into viable options for artificial chaperones which can be exploited in multiple ways. The University of Auckland will host the PI on sabbatical who will study effects of MIPs on folding during this period. The host Dr Laura Domigan, as a visiting researcher, will visit the UK to learn MIP design prior to this, to best support the sabbatical goals.Project partners will support the program throughout, with experience in rational design, sensor application, circular dichroism expertise and folding experience. We will develop the synthetic methods to be scalable through clear step processes, with automation in mind. Potential commercialisation exists through UK based industrial project partners (MIP Diagnostics and Aptamer Group).

3D结构是蛋白质的生物学功能、活性水平和性质的基础。蛋白质与其配体之间的关键相互作用，尽管是小分子或另一种蛋白质，利用特定的结构。因此，一级、二级和三级结构的变化可以导致蛋白质行为的显著变化。这些变化的范围可以从简单的酶活性增加或减少引起的改变其结构（由另一个分子实体的存在引起）;通过在疾病中观察到的错误折叠发病机制，如糖尿病和阿尔茨海默氏症。自然界已经发展出控制机制来调节许多生物系统的结构/功能。这里的大想法是，具有特殊选择性，亲和力和生物相容性的纳米级聚合物材料将作为这些控制机制的仿生学并影响蛋白质行为。我们的愿景是，这些材料将作为特定角色的人工伴侣，开辟了一个新的领域，生物启发材料与一个单一的设计过程，但多个应用程序。拟议的研究计划是一个统一的设计方法，这些人工仿生学的发展使用分子印迹的原则。分子建模技术将确定目标结合位点旁边兼容的聚合物组分。这些简单、优雅的仿生物结合了具有与给定靶标互补的空间和化学功能的结合位点，因此代表了一种通用、通用、可扩展、成本有效的方法来产生合成分子受体。它们目前用于分离科学、纯化、传感器和催化;但这项提议将扩大它们的应用范围，使该技术发挥其真正的潜力。在活动1和2中，纳米级MIP包括aptaMIP（其中PI是主要支持者的核酸杂交体）将靶向特异性结合位点（表位或更大的结构域），目的是调节其靶标的功能。在相关环境中增强或抑制酶活性的能力将被探索，同时建立对这些材料如何相互作用以及组合物/靶位点如何产生所需活性的理解。在活动3和4中，将探索引导蛋白质折叠成特定结构的能力。通过提供有利于结合特定形状或构象的MIP，我们将研究错误折叠的产生，以生产生物材料供进一步使用（组织工程）。我们还将探索这些材料减少或逆转错误折叠本身的潜力，为未来潜在的治疗方法提供概念验证数据。在整个商业和临床相关的目标被用于增加研究的影响，但也显示了开发方法的力量。该项目将使用DMU的设施，并与经验丰富的项目团队合作，这个跨学科的提案涵盖蛋白质，聚合物和分析化学将采取深入的方法MIP合成。它将建立在现有的概念验证思想的基础上，将新的合成过程转化为可以以多种方式利用的人工分子伴侣的可行选择。奥克兰大学将在休假期间主持PI，PI将在此期间研究MIP对折叠的影响。主持人Laura Domigan博士作为访问研究员，将在此之前访问英国学习MIP设计，以最好地支持休假目标。项目合作伙伴将全程支持该计划，在合理设计，传感器应用，圆二色性专业知识和折叠经验方面具有丰富的经验。我们将开发合成方法，通过明确的步骤过程可扩展，并考虑自动化。潜在的商业化存在通过英国的工业项目合作伙伴（MIP诊断和适体集团）。

项目成果

A molecularly imprinted polymer nanoparticle-based surface plasmon resonance sensor platform for antibiotic detection in river water and milk.

基于分子印迹聚合物纳米颗粒的表面等离子共振传感器平台，用于河水和牛奶中的抗生素检测。

• DOI: 10.1007/s00216-022-04012-8
• 发表时间: 2022
• 期刊: Analytical and bioanalytical chemistry
• 影响因子: 4.3
• 作者: Sullivan MV